Fas antigen derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2001
Grant Date -
N/A
app pub date -
Nov 2, 1998
filing date -
May 2, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention provides a novel Fas antigen derivative which comprises at least a part or entire portion of Fas antigen extracellular region polypeptide in which at least one amino acid residue is deleted from a group of amino acid residues starting from the N-terminal amino acid residue of the Fas antigen polypeptide to a cysteine residue most close to the N-terminal side (excluding said cysteine residue), as well as a DNA fragment which encodes Fas antigen derivative, a recombinant DNA molecule which contains DNA sequence, a transformant in which recombinant DNA molecule is introduced, a method for the production of Fas antigen derivative, a medicament which contains novel Fas antigen derivative as the active ingredient and a method for the improvement of activities and functions of Fas antigen and the like.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully